INDUCTION THERAPY IN RENAL TRANSPLANTATION WITH ANTITHYMOCYTE GLOBULIN AND BASILIXIMAB- A SINGLE CENTRE RETROSPECTIVE STUDY

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 52

Abstract

BACKGROUND Renal transplantation is the best available form of renal replacement therapy. Induction therapy pre-transplant reduces the incidence of graft rejections. We present a retrospective study comparing different induction methods in living donor kidney transplantation in our institute. MATERIALS AND METHODS We analysed 423 live kidney transplant recipients of our center from Dec 2010 to Nov 2015, 344 of whom received basiliximab as induction and 79 r-ATG as induction. Primary outcomes like patient survival and graft survival, secondary outcomes like graft rejections, infections, PTDM, recurrence of disease were compared. RESULTS 5yr patient survival rates were observed to be 91% and 88% respectively whereas graft survival rates were 93% and 86% respectively for ATG and basiliximab. Incidence of rejections was similar (p=0.867). Cellular rejections were more common with basiliximab (7.9% vs. 3.8%) but statistically not significant (P=0.498). Infections in the post-operative period were more common in r-ATG arm especially LRTI (P=0.011) and diarrhoeal episodes (P=0.005). Incidence of cytopenias was more in rATG arm during hospital stay (10.1 vs. 2.6% P=0.002) and also the later followup period (25 vs. 12.4% P<0.001). Incidence of PTDM was more in basiliximab (33.8% vs. 22.8%) arm but not significant (P=0.061). CONCLUSION ATG and basiliximab are non-inferior to one another as induction therapy. ATG is effective in high immunological risk groups with equivalent graft and patient survival with increased risk of Lower respiratory tract infections and diarrhoea in immediate post-transplant periods and increased risk for cytopenias compared to basiliximab. Basiliximab has slightly increased risk of post-transplant diabetes mellitus. Careful selection of the agent in an individual based on risk rather than a question of efficacy of agents is the key to successful transplantation.

Authors and Affiliations

Hareesh M. V. K, Sharma R. K.

Keywords

Related Articles

NEAR MISS CASE OF HUS ASSOCIATED WITH IGA NEPHROPATHY IN PREGNANCY

BACKGROUND Glomerular disease in pregnancy should be planned in patients who are in remission to decrease fetomaternal complications. Renal diseases can masquerading as preeclampsia at presentation. A renal biopsy is par...

TYMPANOPLASTY TYPE I EVALUATION OF THE SURGICAL RESULTS AND ITS IMPACT AS THE TREATMENT MODALITY IN CHRONIC OTITIS MEDIA

BACKGROUND Chronic Otitis Media (COM), mucosal disease is a common ailment with which patients present to the ENT outpatient department. Tympanoplasty is the surgery performed with the goals of establishing an intact tym...

EVALUATION OF EARLY LYMPH NODE METASTASIS IN SQUAMOUS CELL CARCINOMA OF THE PENIS WITH THE AID OF p53 IMMUNOMARKER

BACKGROUND Use of p53 as a prognostic marker to detect early lymph node metastasis in carcinoma of penis in order to avoid unnecessary lymphadenectomy was evaluated. The aim of the study is to detect early metastasis in...

ANESTHETIC CONSIDERATIONS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Chronic obstructive pulmonary disease (COPD) is a spectrum of diseases that includes emphysema, chronic bronchitis, and small airway disease. It is characterized by progressive increased resistance to breathing. Patients...

PREVALENCE OF SUBSTANCE ABUSE AMONG ADOLESCENTS AND YOUNG ADULTS IN RURAL BANGALORE- AN EPIDEMIOLOGICAL STUDY

BACKGROUND According to world drug report, youth from urban settings have been topping the charts for drug abuse. The alarming rate of drug abuse and especially the increase of drug abuse among youngsters has had detrime...

Download PDF file
  • EP ID EP608444
  • DOI 10.18410/jebmh/2018/723
  • Views 73
  • Downloads 0

How To Cite

Hareesh M. V. K, Sharma R. K. (2018). INDUCTION THERAPY IN RENAL TRANSPLANTATION WITH ANTITHYMOCYTE GLOBULIN AND BASILIXIMAB- A SINGLE CENTRE RETROSPECTIVE STUDY. Journal of Evidence Based Medicine and Healthcare, 5(52), 3545-3551. https://europub.co.uk./articles/-A-608444